Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination

Yen, 2006, Thyroid hormone action at the cellular, genomic and target gene levels, Molecular and Cellular Endocrinology, 246, 121, 10.1016/j.mce.2005.11.030 Psarra, 2006, The mitochondrion as a primary site of action of steroid and thyroid hormones: presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells, Molecular and Cellular Endocrinology, 246, 21, 10.1016/j.mce.2005.11.025 Silva, 2006, Thermogenic mechanisms and their hormonal regulation, Physiological Reviews, 86, 435, 10.1152/physrev.00009.2005 Mousa, 2006, Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (ditpa) is initiated at the cell surface and is integrin mediated, Endocrinology, 147, 1602, 10.1210/en.2005-1390 Farwell, 2006, Dynamic non-genomic actions of thyroid hormone in the developing rat brain, Endocrinology, 147, 2567, 10.1210/en.2005-1272 Hart, 2006, Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues, Journal of Medicinal Chemistry, 49, 1101, 10.1021/jm0505718 Chiellini, 2007, Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function, The FASEB Journal, 21, 1597, 10.1096/fj.06-7474com Dunn, 2001, Update on intrathyroidal iodine metabolism, Thyroid, 11, 407, 10.1089/105072501300176363 Köhrle, 2005, Selenium, the thyroid, and the endocrine system, Endocrine Reviews, 26, 944, 10.1210/er.2001-0034 Kohrle, 2005, Selenium and the control of thyroid hormone metabolism, Thyroid, 15, 841, 10.1089/thy.2005.15.841 Beckett, 1993, Species differences in thyroidal iodothyronine deiodinase expression and the effect of selenium deficiency on its activity, Journal of Trace Elements and Electrolytes in Health and Disease, 7, 123 Maia, 2005, Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans, The Journal of Clinical Investigation, 115, 2524, 10.1172/JCI25083 Jakobs, 1997, The promotor of the human type I 5′-deiodinase gene: mapping of the transcription start site and identification of a DR+4 thyroid hormone responsive element, European Journal of Biochemistry, 247, 288, 10.1111/j.1432-1033.1997.00288.x Bianco, 2006, Deiodinases: implications of the local control of thyroid hormone action, The Journal of Clinical Investigation, 116, 2571, 10.1172/JCI29812 Bianco, 2002, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocrine Reviews, 23, 38, 10.1210/er.23.1.38 Ambroziak, 2003, Pax-8 expression correlates with Type II 5′ deiodinase expression in thyroids from patients with Graves' disease, Thyroid, 13, 141, 10.1089/105072503321319440 Laurberg, 1981, Iodothyronine secretion from perfused dog thyroid lobes after prolonged thyrotropin treatment in vivo, Endocrinology, 109, 1560, 10.1210/endo-109-5-1560 Selmi-Ruby, 1996, Analysis of the functional state of T3 nuclear receptors expressed in thyroid cells, Molecular and Cellular Endocrinology, 119, 95, 10.1016/0303-7207(96)03801-4 Friesema, 2006, Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8, Nature Clinical Practice. Endocrinology & Metabolism, 2, 512, 10.1038/ncpendmet0262 Leonard, 2001, Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase, The Journal of Biological Chemistry, 276, 2600, 10.1074/jbc.M006973200 Curcio-Morelli, 2003, In vivo dimerization of Types 1, 2, and 3 iodothyronine selenodeiodinases, Endocrinology, 144, 937, 10.1210/en.2002-220960 Leonard, 2005, Characterization of the protein dimerization domain responsible for assembly of functional selenodeiodinases, The Journal of Biological Chemistry, 280, 11093, 10.1074/jbc.M500011200 Simpson, 2006, Identification of the key residues responsible for the assembly of selenodeiodinases, The Journal of Biological Chemistry, 281, 14615, 10.1074/jbc.M600783200 Zeold, 2006, Metabolic instability of type 2 deiodinase is transferable to stable proteins independently of subcellular localization, The Journal of Biological Chemistry, 281, 31538, 10.1074/jbc.M604728200 Kuiper, 2005, Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast, Journal of Molecular Endocrinology, 34, 865, 10.1677/jme.1.01770 Montero-Pedrazuela, 2003, Divergent expression of type 2 deiodinase and the putative thyroxine- binding protein p29, in rat brain, suggests that they are functionally unrelated proteins, Endocrinology, 144, 1045, 10.1210/en.2002-220823 Köhrle, 2000, Expression of type II 5′-deiodinase (5′DII) and plasma glutathione peroxidase (pGPx) in human thyroid, Endocrine Journal, 47 Ohba, 2001, Identification of two novel splicing variants of human type II iodothyronine deiodinase mRNA, Molecular and Cellular Endocrinology, 172, 169, 10.1016/S0303-7207(00)00368-3 Kasahara, 2006, Regulation of iodothyronine deiodinase and roles of thyroid hormones in human coronary artery smooth muscle cells, Atherosclerosis, 186, 207, 10.1016/j.atherosclerosis.2005.07.018 Maeda, 2003, Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells, Molecular and Cellular Endocrinology, 200, 111, 10.1016/S0303-7207(02)00409-4 Friesema, 2006, Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism, Molecular Endocrinology, 20, 2761, 10.1210/me.2005-0256 Nicoloff, 1984, Peripheral autoregulation of thyroxine to triiodothyronine conversion in man, Hormone and Metabolic Research. Supplement Series, 14, 74 Nguyen, 1998, Direct measurement of the contributions of type I and type II 5′-deiodinases to whole body steady state 3,5,3′-triiodothyronine production from thyroxione in the rat, Endocrinology, 139, 4626, 10.1210/en.139.11.4626 Leonard, 2000, Intracellular pathways of thyroid hormone metabolism, 136 Schomburg, 2006, Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice, Endocrinology, 147, 1306, 10.1210/en.2005-1089 Streckfuss, 2005, Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice, Biochemical and Biophysical Research Communications, 337, 739, 10.1016/j.bbrc.2005.09.102 Chanoine, 1993, The thyroid gland is a major source of circulating T3 in the rat, The Journal of Clinical Investigation, 91, 2709, 10.1172/JCI116510 Köhrle, 2002, Iodothyronine deiodinases, Methods in Enzymology, 347, 125, 10.1016/S0076-6879(02)47014-0 Ziouzenkova, 2007, Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses, Molecular Endocrinology, 21, 77, 10.1210/me.2006-0225 Kuiper, 2003, Molecular basis for the substrate selectivity of cat Type I iodothyronine deiodinase, Endocrinology, 144, 5411, 10.1210/en.2003-0728 Hatfield, 2002, How selenium has altered our understanding of the genetic code, Molecular and Cellular Biology, 22, 3565, 10.1128/MCB.22.11.3565-3576.2002 Sun, 2002, Nonsense-mediated decay: assaying for effects on selenoprotein mRNAs, Methods in Enzymology, 347, 49, 10.1016/S0076-6879(02)47007-3 Muller, 2003, 3′UTRs of glutathione peroxidases differentially affect selenium-dependent mRNA stability and selenocysteine incorporation efficiency, Biological Chemistry, 384, 11, 10.1515/BC.2003.002 Riese, 2006, Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues, Endocrinology, 147, 5883, 10.1210/en.2006-0689 Dumitrescu, 2005, Mutations in SECISBP2 result in abnormal thyroid hormone metabolism, Nature Genetics, 37, 1247, 10.1038/ng1654 Curcio, 2001, The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line, The Journal of Biological Chemistry, 276, 30183, 10.1074/jbc.C100325200 Kim, 2003, Overexpression of Type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels, The Journal of Clinical Endocrinology and Metabolism, 88, 594, 10.1210/jc.2002-020921 Köhrle, 1997, Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5′-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers, Current Topics in Pathology, 91, 83, 10.1007/978-3-642-60531-4_8 Schmutzler, 2000, Retinoic acid redifferentiation therapy for thyroid cancer, Thyroid, 10, 393, 10.1089/thy.2000.10.393 Schmutzler, 2004, Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses, European Journal of Endocrinology, 150, 547, 10.1530/eje.0.1500547 Huang, 2002, A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing Type 3 iodothyronine deiodinase, The Journal of Clinical Endocrinology and Metabolism, 87, 4457, 10.1210/jc.2002-020627 Draper, 2005, 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action, The Journal of Endocrinology, 186, 251, 10.1677/joe.1.06019 Masuda, 2006, Evidence for the activation of 1alpha-hydroxyvitamin D(2) by 25-hydroxyvitamin D-24-hydroxylase: Delineation of pathways involving 1alpha,24-dihydroxyvitamin D(2) and 1alpha,25-dihydroxyvitamin D(2), Biochimica et Biophysica Acta, 1761, 221, 10.1016/j.bbalip.2006.01.004 Mindnich, 2004, The role of 17 beta-hydroxysteroid dehydrogenases, Molecular and Cellular Endocrinology, 218, 7, 10.1016/j.mce.2003.12.006 Bookout, 2006, Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network, Cell, 126, 789, 10.1016/j.cell.2006.06.049 Qatanani, 2005, Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism, Endocrinology, 146, 995, 10.1210/en.2004-1350 De Groot, 1999, Dangerous dogmas in medicine: the nonthyroidal illness syndrome, The Journal of Clinical Endocrinology and Metabolism, 84, 151, 10.1210/jc.84.1.151 Boelen, 2006, Contributions of cytokines to nonthyroidal illness, Current Opinion in Endocrinology and Diabetes, 13, 444, 10.1097/01.med.0000244227.21776.70 Hesch, 1981 Peeters, 2006, Changes within the thyroid axis during critical illness, Critical Care Clinics, 22, 41, 10.1016/j.ccc.2005.08.006 Boelen, 2005, Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation, Endocrinology, 146, 5128, 10.1210/en.2005-0608 Peeters, 2005, Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity, The Journal of Clinical Endocrinology and Metabolism, 90, 6460, 10.1210/jc.2005-0866 Wu, 2005, Alternate pathways of thyroid hormone metabolism, Thyroid, 15, 943, 10.1089/thy.2005.15.943 Angstwurm, 1999, Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome, Critical Care Medicine, 27, 1807, 10.1097/00003246-199909000-00017 Fekete, 2005, Ascending brainstem pathways are not involved in lipopolysaccharide-induced suppression of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus, Endocrinology, 146, 1357, 10.1210/en.2004-1429 Alkemade, 2006, Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary, European Journal of Endocrinology, 154, 491, 10.1530/eje.1.02111 Baur, 2000, Effects of proinflammatory cytokines on anterior pituitary 5′- deiodinase type I and type II, The Journal of Endocrinology, 167, 505, 10.1677/joe.0.1670505 Boelen, 2004, Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness, Hormone and Metabolic Research, 36, 101, 10.1055/s-2004-814219 Baur, 2002, Expression of 5′-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas, European Journal of Endocrinology, 147, 263, 10.1530/eje.0.1470263 Christoffolete, 2006, Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism, Endocrinology, 147, 1735, 10.1210/en.2005-1300 Boelen, 2006, Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake, The Journal of Endocrinology, 191, 707, 10.1677/joe.1.07056 Tannahill, 2002, Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours, Clinical Endocrinology, 56, 735, 10.1046/j.1365-2265.2002.01541.x Heuer, 2005, The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone sensitive neuron populations, Endocrinology, 146, 1701, 10.1210/en.2004-1179 Bernal, 2006, Role of monocarboxylate anion transporter 8 (MCT8) in thyroid hormone transport: answers from mice, Endocrinology, 147, 4034, 10.1210/en.2006-0695 Jakobs, 2002, Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells, European Journal of Endocrinology, 146, 559, 10.1530/eje.0.1460559 Koenig, 2005, Regulation of type 1 iodothyronine deiodinase in health and disease, Thyroid, 15, 835, 10.1089/thy.2005.15.835 Kwakkel, 2006, Differential involvement of nuclear factor-{kappa}B and activator protein-1 pathways in the interleukin-1{beta}-mediated decrease of deiodinase type 1 and thyroid hormone receptor {beta}1 mRNA, The Journal of Endocrinology, 189, 37, 10.1677/joe.1.06354 Zeold, 2006, Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene, Endocrinology, 147, 4419, 10.1210/en.2005-1608 Yu, 2006, Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice, Endocrinology, 147, 3580, 10.1210/en.2005-1443 Forhead, 2006, Developmental control of iodothyronine deiodinases by cortisol in the ovine fetus and placenta near term, Endocrinology, 147, 5988, 10.1210/en.2006-0712 Grarup, 2007, Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7,342 Danish whites, The Journal of Clinical Endocrinology and Metabolism, 92, 363, 10.1210/jc.2006-1958 Mentuccia, 2005, The Thr92Ala deiodinase Type 2 (DIO2) variant is not associated with Type 2 diabetes or indices of insulin resistance in the old order of Amish, Thyroid, 15, 1223, 10.1089/thy.2005.15.1223 Canani, 2005, The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus, The Journal of Clinical Endocrinology and Metabolism, 90, 3472, 10.1210/jc.2004-1977 Appelhof, 2005, Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy, The Journal of Clinical Endocrinology and Metabolism, 90, 6296, 10.1210/jc.2005-0451 Eisenberg, 2006, L-T4 bioequivalence and hormone replacement studies via feedback control simulations, Thyroid, 16, 1279, 10.1089/thy.2006.16.1279 Peeters, 2006, Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases, European Journal of Endocrinology, 155, 655, 10.1530/eje.1.02279 Brabant, 2006, Is there a need to redefine the upper normal limit of TSH?, European Journal of Endocrinology, 154, 633, 10.1530/eje.1.02136 Volzke, 2005, Reference intervals of serum thyroid function tests in a previously iodine-deficient area, Thyroid, 15, 279, 10.1089/thy.2005.15.279 Weitzel, 2003, Regulation of mitochondrial biogenesis by thyroid hormone, Quarterly Journal of Experimental Physiology, 88, 121, 10.1113/eph8802506 Barker, 1952, Metabolism of tissues excised from thyroxine-injected rats, The American Journal of Physiology, 170, 81, 10.1152/ajplegacy.1952.170.1.81 Hansen, 2006, Regulatory circuits controlling white versus brown adipocyte differentiation, The Biochemical Journal, 398, 153, 10.1042/BJ20060402 Cinti, 2006, The role of brown adipose tissue in human obesity, Nutrition, Metabolism and Cardiovascular Diseases, 16, 569, 10.1016/j.numecd.2006.07.009 Watanabe, 2006, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, Nature, 439, 484, 10.1038/nature04330 Lechan, 2006, The TRH neuron: a hypothalamic integrator of energy metabolism, vol. 153 Fliers, 2006, Hypothalamic thyroid hormone feedback in health and disease, vol. 153 Jakobs, 1997, Structure of the human Type I iodothyronine 5′-deiodinase gene and localization to chromosome 1p32-p33, Genomics, 42, 361, 10.1006/geno.1997.4736 Celi, 2000, Structural organization and chromosomal localization of the human type II deiodinase gene, European Journal of Endocrinology, 143, 267, 10.1530/eje.0.1430267 Hernandez, 1998, Localization of the type 3 iodothyronine deiodinase (DIO3) gene to human chromosome 14q32 and mouse chromosome 12F1, Genomics, 53, 119, 10.1006/geno.1998.5505 Kim, 2004, A Novel cell type-specific mechanism for thyroid hormone-dependent negative regulation of the human type 1 deiodinase gene, Molecular Endocrinology, 18, 2924, 10.1210/me.2004-0255 Hernandez, 2003, Activity and response to serum of the mammalian thyroid hormone deiodinase 3 gene promoter: identification of a conserved enhancer, Molecular and Cellular Endocrinology, 206, 23, 10.1016/S0303-7207(03)00239-9